Name	Last Trade		Change
CTIX - OBB	$0.95		0.05 5.56%
CELLCEUTIX CORP
1 YEAR CHART News Clinical Trials for Cellceutix Novel Anti-Cancer Drug Now Active at Leading HospitalsMarketwire (Mon 7:00am) Valiant Is On An Acquisition Spree - Will Prurisol Get Under Big Pharma's Skin?at Seeking Alpha (Thu, Oct 18) CELLCEUTIX CORP Files SEC form 10-K, Annual ReportEDGAR Online (Fri, Oct 12) Interview With Leo Ehrlich, CEO Of Cellceutixat Seeking Alpha (Tue, Oct 9)